Profound Medical Corp
TSX:PRN

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
TSX:PRN
Watchlist
Price: 8.17 CAD
Market Cap: 245.5m CAD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one PRN stock under the Base Case scenario is hidden CAD. Compared to the current market price of 8.17 CAD, Profound Medical Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

15.1
P/S
P/S
Price to Sales
15.1
vs History
88
vs Industry
7
Median 3Y
24.9
Median 5Y
29.1
Industry
2.3
Forward
9.8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-7.6
Industry
22
Forward
-5.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-9.5
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-8.7
Industry
19.9
More Details
3.5
P/B
P/B
Price to Book Value
3.5
vs History
63
vs Industry
26
Median 3Y
4.4
Median 5Y
3.9
Industry
2.2
More Details
11.6
EV/S
EV/S
Enterprise Value to Sales
11.6
vs History
87
vs Industry
9
Median 3Y
19.8
Median 5Y
23.4
Industry
2.4
Forward
7.5
More Details
17.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
17.1
vs History
88
vs Industry
8
Median 3Y
36.5
Median 5Y
44.4
Industry
4.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-6.1
Industry
11.6
Forward
-3.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-5.2
Median 5Y
-5.9
Industry
15.9
Forward
-3.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-6.8
Median 5Y
-7.5
Industry
14.2
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-6.8
Median 5Y
-7.5
Industry
17.8
More Details
10.3
EV/IC
EV/IC
Enterprise Value to IC
10.3
vs History
66
vs Industry
7
Median 3Y
11
Median 5Y
11.9
Industry
1.8
More Details

Multiples Across Competitors

PRN Competitors Multiples
Profound Medical Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Profound Medical Corp
TSX:PRN
245.5m CAD 15.1 -5.6 -3.9 -3.8
US
Abbott Laboratories
NYSE:ABT
232.2B USD 5.5 17.2 22.3 32.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD 21.6 76.1 61.4 74.4
US
Boston Scientific Corp
NYSE:BSX
154.1B USD 8.7 75 35.7 49.1
US
Stryker Corp
NYSE:SYK
151.1B USD 6.5 53.1 26.1 31.5
IE
Medtronic PLC
NYSE:MDT
115.3B USD 3.4 24.8 13.8 19.7
DE
Siemens Healthineers AG
XETRA:SHL
53.5B EUR 2.3 25.7 14.3 19.9
US
Becton Dickinson and Co
NYSE:BDX
50.9B USD 2.5 33.8 13.3 25
US
Edwards Lifesciences Corp
NYSE:EW
45.9B USD 8.3 11 25.1 27.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
43.9B USD 11.2 49.2 34.8 38.9
US
Resmed Inc
NYSE:RMD
38.1B USD 7.6 29 20.7 23.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Profound Medical Corp
TSX:PRN
Average EV/EBITDA: 26.8
Negative Multiple: -3.9 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.3
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
61.4
24%
2.6
US
Boston Scientific Corp
NYSE:BSX
35.7
21%
1.7
US
Stryker Corp
NYSE:SYK
26.1
12%
2.2
IE
Medtronic PLC
NYSE:MDT
13.8
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
14.3
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.3
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
25.1
12%
2.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.8
12%
2.9
US
Resmed Inc
NYSE:RMD
20.7
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Profound Medical Corp
TSX:PRN
Average EV/EBIT: 34.2
Negative Multiple: -3.8 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
32.2
22%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
74.4
26%
2.9
US
Boston Scientific Corp
NYSE:BSX
49.1
31%
1.6
US
Stryker Corp
NYSE:SYK
31.5
16%
2
IE
Medtronic PLC
NYSE:MDT
19.7
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.9
19%
1
US
Becton Dickinson and Co
NYSE:BDX
25
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27.7
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.9
12%
3.2
US
Resmed Inc
NYSE:RMD
23.5
14%
1.7

See Also

Summary
PRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRN stock valuation using valuation multiples.
Wall Street Estimates
PRN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 266,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.